Showing results (51-60 of 133) with videos related to
Sort By:
Pageof 14
Molecular Genetics and Metabolism|May 27, 2014
Systemic accumulation of undigested lysosomal metabolites in an autopsy case of mucolipidosis type II; autophagic dysfunction in cardiomyocyteYohei Sato, Hiroshi Kobayashi, Shun Sato, et al.Cancer Letters|April 13, 2011
Combination treatment using adenovirus vector-mediated tumor necrosis factor-alpha gene transfer and a NF-κB inhibitor for pancreatic cancer in miceKenei Furukawa, Toya Ohashi, Koichiro Haruki, et al.Journal of Hepato-Biliary-Pancreatic Sciences|April 13, 2011
Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibitionYuki Fujiwara, Kenei Furukawa, Koichiro Haruki, et al.Pancreas|February 24, 2011
Combination paclitaxel and inhibitor of nuclear factor κB activation improves therapeutic outcome for model mice with peritoneal dissemination of pancreatic cancerYuki Fujiwara, Kenei Furukawa, Yohta Shimada, et al.Oncology Reports|September 3, 2010
Anti-tumor effect by inhibition of NF-kappaB activation using nafamostat mesilate for pancreatic cancer in a mouse modelKenei Furukawa, Tomonori Iida, Hiroaki Shiba, et al.Artificial Organs|May 26, 2010
A thermoreversible polymer mediates controlled release of glial cell line-derived neurotrophic factor to enhance kidney regenerationYousof Gheisari, Takashi Yokoo, Kei Matsumoto, et al.Molecular Therapy. Methods & Clinical Development|July 23, 2015
Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patientYohei Sato, Hiroshi Kobayashi, Takashi Higuchi, et al.The Journal of Surgical Research|December 6, 2016
New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancerTakashi Horiuchi, Tadashi Uwagawa, Yoshihiro Shirai, et al.Journal of the American College of Surgeons|December 11, 2012
Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in miceYuki Fujiwara, Hiroaki Shiba, Ryota Iwase, et al.Auris, Nasus, Larynx|November 11, 2009
Inner ear pathology of alpha-galactosidase A deficient mice, a model of Fabry diseaseYuika Sakurai, Rie Suzuki, Ryuichi Yoshida, et al.Pageof 14